The Business of Biotech - Interview with Jay Flatley, CEO of Illumina, Part One - August 8, 2010 - Segment Two

The Business of Biotech - Interview with Jay Flatley, Chief Executive Officer of Illumina, specializing in genome sequencing. Illumina’s Individual Genome Sequencing service can provide you with the most comprehensive information on your genome from the world’s experts in genetic analysis. Learn about your ancestry, potential response to drugs, and predisposition to health conditions. Uncover your story.

Illumina was founded in 1998 with the vision of becoming the world’s leading provider of integrated tools and services that advance the understanding of genetics and health. Today, their platforms and assays are helping make studies possible that were not even imaginable just a few years ago. Whether enabling researchers to discovering the genetic underpinnings of disease risk or individuals to better understand their genome, their technologies provide the most accurate, comprehensive translation of what’s present in our DNA.

2Minutes&More with Betsy Berkhemer and Renee Fraser airs every Sunday at 1pm on KFWB NEWS TALK 980. Tune in for a full hour of tips for business success.